Buprenorphine for Dogs: Uses, Dosage & Side Effects

See your vet immediately if your dog has trouble breathing, collapses, becomes extremely hard to wake, or shows severe weakness after receiving buprenorphine. This medication is a controlled opioid, so it should only be used exactly as your vet directs.

This article is educational and cannot replace an exam. The right dose, route, and monitoring plan depend on your dog's size, age, pain level, other medications, and liver, kidney, heart, or lung health.

Never give human buprenorphine products to your dog unless your vet specifically prescribed that exact product and dose. Different formulations have very different concentrations, and dosing errors can be dangerous.

Buprenorphine is an opioid pain medication your vet may use to control short-term pain in dogs. It is a partial mu-opioid agonist, which means it binds strongly to opioid receptors and can provide meaningful pain relief, but it does not act exactly like full opioids such as morphine or hydromorphone.

In dogs, buprenorphine is most often used around surgery, dental procedures, or injuries. It is commonly given in the hospital by injection, though some dogs may receive a liquid form placed into the cheek pouch for absorption through the mouth tissues rather than swallowed like a typical oral medication.

Most use in dogs is off-label, which is common and legal in veterinary medicine when your vet determines it is appropriate. That matters because the exact product, concentration, route, and schedule can vary a lot from one case to another.

Buprenorphine is mainly used for acute pain, especially after spay or neuter surgery, mass removals, dental extractions, wound repair, and other procedures where dogs need opioid-level pain support for a short period. It may also be used before anesthesia as part of a premedication plan.

Your vet may choose buprenorphine when a dog needs opioid pain control but may not need a stronger full opioid for the entire recovery period. It is also commonly combined with other treatments, such as an NSAID, local anesthetic block, or gabapentin, because pain control often works best when different pathways are addressed together.

It is usually not the main long-term choice for chronic osteoarthritis or other ongoing pain conditions. In those cases, your vet may discuss other options that are easier to use at home and better suited for longer treatment.

Buprenorphine dosing in dogs depends on the formulation and route. Veterinary references list standard injectable dosing around 0.005 to 0.03 mg/kg IV or IM every 4 to 6 hours for acute pain. Some references also list transmucosal dosing around 0.12 mg/kg every 4 to 8 hours, though not every dog absorbs oral-mucosal dosing the same way, so your vet may prefer injection in many cases.

For some hospital patients, buprenorphine may be used as a continuous rate infusion (CRI) after a loading dose. Sustained-release buprenorphine formulations are also used in some dogs, with references listing 0.03 to 0.06 mg/kg SC as a single injection in selected cases. Product choice matters because concentrated long-acting formulations are not interchangeable with standard injectable buprenorphine.

Onset is often within about 30 minutes to 1 hour, and standard formulations are generally considered short-acting, though effects may last longer in dogs with liver or kidney disease. Because this is a potent controlled drug, your vet should calculate the exact dose and schedule for your dog rather than relying on general online charts.

The most common side effect in dogs is sleepiness or sedation. Some dogs also seem quieter than usual, less interested in food for a short time, or mildly wobbly after treatment. Mild nausea, vomiting, or temporary changes in heart rate can happen in some patients.

More serious opioid effects are less common but matter. Watch for slow or labored breathing, extreme sedation, collapse, marked weakness, or unusual agitation. Rare dogs may show the opposite of sedation and become restless or dysphoric.

Injection-site discomfort can occur with some formulations. Because buprenorphine can affect breathing and cardiovascular function, dogs with head trauma, neurologic disease, heart disease, lung disease, liver disease, kidney disease, Addison's disease, or severe debilitation may need closer monitoring and dose adjustments from your vet.

Buprenorphine can interact with other medications that slow the central nervous system. That includes benzodiazepines, sedatives, anesthetic drugs, and other opioids. When these combinations are used intentionally in the hospital, your vet adjusts doses and monitors breathing, heart rate, and recovery closely.

Because buprenorphine binds tightly to opioid receptors, it can also reduce or complicate the effect of full opioid agonists if your dog needs to switch pain plans. This is one reason your vet may be very specific about timing when changing from one opioid to another.

Other reported interactions include certain azole antifungals, erythromycin, phenobarbital, tramadol, metoclopramide, cisapride, desmopressin, fentanyl, and selegiline. Always tell your vet about every prescription, supplement, and flea or tick product your dog receives.

Usually yes for routine meals, but the medication itself should only be given the way your vet instructs.

There are no well-established breed statistics showing that certain dog breeds routinely need buprenorphine more often than others. In practice, procedure type, body weight, age, and medical history matter more than breed. Toy breeds may need very small measured doses, while giant breeds may need careful reassessment because pain control does not scale by size alone.

Breed-specific approval: None

Most important factor: Body weight and overall health

Extra caution groups: Very young, senior, debilitated, liver or kidney disease, heart or lung disease

Known MDR1-specific warning: Not a primary breed-specific concern listed for buprenorphine